« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 17, Issue 2
, Pages
205-213
, February 2011
Mycophenolic Acid Inhibits Natural Killer Cell Proliferation and Cytotoxic Function: A Possible Disadvantage of Including Mycophenolate Mofetil in the Graft-Versus-Host Disease Prophylaxis Regimen
-
Effect of immunosuppressants on the proliferation of NK cells induced by IL-2 and IL-15. (A) NK cells isolated from healthy individuals were cultured in the presence of IL-2 (100 U/mL) and IL-15 (10 n
Effect of immunosuppressants on the proliferation of NK cells induced by IL-2 and IL-15. (A) NK cells isolated from healthy individuals were cultured in the presence of IL-2 (100 U/mL) and IL-15 (10 ng/mL) with a vehicle control (EtOH 0.1%, MPA 10 μg/mL, CSP 1000 ng/mL, TAC 20 ng/mL, or MTX 100 ng/mL) for 7 days. The vertical axis represents the fold expansion (mean ± SD; n = 6) of NK cells calculated by dividing the number of cells after culture by that before culture. An asterisk indicates values showing significantly less degree of proliferation (P <.05) than the vehicle controls. (B) CFSE contents in CD3-CD56+ cells were determined using flow cytometry at days 1, 5, and 9 of culture. The figure shows a representative set of histograms from a healthy individual. The results from 5 other individuals showed similar results. (C) NK cells were cultured in the presence of IL-2 (100 U/mL) and IL-15 (10 ng/mL) with MPA (1-100 μg/mL) for 7 days. The vertical axis represents the fold expansion (mean ± SD; n = 4) of NK cells calculated by dividing the number of cells after culture by that before culture. An asterisk indicates values showing significantly less proliferation (P <.05) compared with the vehicle controls.
-
Changes in the NK cell phenotype after a 1-week culture with different immunosuppressants. NK cells were cultured in the presence of IL-2 (100 U/mL) and IL-15 (10 ng/mL) with different immunosuppressaChanges in the NK cell phenotype after a 1-week culture with different immunosuppressants. NK cells were cultured in the presence of IL-2 (100 U/mL) and IL-15 (10 ng/mL) with different immunosuppressants or a vehicle for 7 days, and the percentages of CD56dimCD16+ and CD56higCD16- cells before and after culture were determined. (A) Scattergrams of a representative donor from 4 different ones. The analyses of other individuals produced similar results. (B) The percentages of CD56highCD16- NK cells in the total CD3-CD56+ cells after culture in the presence of various immunosuppressants. The y-axis represents the mean percentage ± SD of CD56highCD16- NK cells calculated from 4 different experiments. An asterisk indicates a value showing a significant difference in the CD56highCD16- NK cell percentage compared with the vehicle control.
-
Changes in the expression of NK cell–activating receptors after culture with immunosuppressants. The changes in the expression levels of NKp30, NKp44, NKp46, and NKG2D in NK cells from 5 different indChanges in the expression of NK cell–activating receptors after culture with immunosuppressants. The changes in the expression levels of NKp30, NKp44, NKp46, and NKG2D in NK cells from 5 different individuals after a 1-week culture with immunosuppressants are shown. The vertical axis represents relative changes in the geometric MFI (gMFI) that is calculated by (gMFI of the receptor in each immunosuppressant -gMFI of the receptor in control)/gMFI of the receptor in control) × 100. An asterisk indicates a significant difference compared with the vehicle control. “–” denotes the mean of the relative change.
-
Cytotoxicity of cultured NK cells against leukemia cell lines. (A) Cytotoxicities by NK cells against K562 and Daudi cells at a 1:1 E:T ratio after the 1-week culture in the presence of different immuCytotoxicity of cultured NK cells against leukemia cell lines. (A) Cytotoxicities by NK cells against K562 and Daudi cells at a 1:1 E:T ratio after the 1-week culture in the presence of different immunosuppressants were compared. The mean ± SD cytotoxicity from experiments using 3 different donors is shown. An asterisk indicates a significant difference compared with the control. (B) Cytotoxicities by NK cells against K562 and Daudi cells at a 1:1 E:T ratio after the 1-week culture in the presence of different concentration of MPA were compared. The mean ± SD cytotoxicities of experiments using NK cells from 3 different donors are shown.
-
Effect of guanosine on the MPA-induced NK cell inhibition. NK cells were cultured in the presence of 10 μg/mL MPA with or without 100 μM guanosin for 1 week, and the effects of guanosine on MPA-induceEffect of guanosine on the MPA-induced NK cell inhibition. NK cells were cultured in the presence of 10 μg/mL MPA with or without 100 μM guanosin for 1 week, and the effects of guanosine on MPA-induced NK cell growth inhibition (A) and cytotoxicity inhibition (B) were assessed. The vertical axis in A and B represent the mean ± SD of the fold expansion calculated by dividing the cell number after culture by that before culture and of the cytotoxicity by cultured NK cells against K562 cells at a 1:1 E/T ratio determined from 4 different donors. An asterisk indicates a significant difference (P <.05) compared with vehicle controls.
-
Effect of MPA on p27Kip1 expression by T cells and NK cells. T cells and NK cells were harvested at the indicated time points after culture in the presence of IL-2 (100 U/mL) with or without MPA (10 μEffect of MPA on p27Kip1 expression by T cells and NK cells. T cells and NK cells were harvested at the indicated time points after culture in the presence of IL-2 (100 U/mL) with or without MPA (10 μg/mL), and p27Kip1 protein in the T cell and NK cell lysate was detected by Western blot analysis with anti-p27Kip1–specific monoclonal antibody. The figure shows representative results from 5 experiments.
Financial disclosure: See Acknowledgments on page 212.
PII: S1083-8791(10)00353-8
doi: 10.1016/j.bbmt.2010.08.014
© 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 17, Issue 2
, Pages
205-213
, February 2011
